Summary of ALL-STAR Nordic status data, including recruitment status, demographics, clinical outcomes, age at diagnosis, and data availability by country.
About ALL-STAR Nordic
Acute lymphoblastic leukemia (ALL) is the most common cancer among children and adolescents. Treatment is life-saving, but survivors may experience late effects that can affect physical health, cognition, daily function, quality of life, and long-term well-being.
ALL-STAR studies the frequency and type of late effects after ALL and aims to identify early risk factors so follow-up care and prevention can be improved. The Nordic status overview below summarizes recruitment, clinical outcomes, and data availability across participating countries.
Recruitment status by country
Stacked counts for included, declined, and pending records.
Overall recruitment status
Distribution based on table totals.
Consent rate by country
Included records as percentage of all recruitment status records.
Data availability by country
Counts by data type. Missing/not applicable values are left blank.
Specific data completeness totals
Total number of available records per measure.
Patient overview by country
Total patients and recruited/consented patients.
Median age at diagnosis
Years, based on total patient rows.
Clinical outcomes by country
HSCT, relapse, mortality, and LTFU counts from total patient rows.